Catalyst Funds Management Pty Ltd Invests $1.56 Million in Molina Healthcare, Inc $MOH

Catalyst Funds Management Pty Ltd acquired a new stake in shares of Molina Healthcare, Inc (NYSE:MOH) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 9,000 shares of the company’s stock, valued at approximately $1,562,000.

Other hedge funds have also recently made changes to their positions in the company. Blue Trust Inc. raised its stake in Molina Healthcare by 23.8% in the 4th quarter. Blue Trust Inc. now owns 322 shares of the company’s stock worth $56,000 after acquiring an additional 62 shares during the last quarter. Applied Finance Capital Management LLC grew its stake in Molina Healthcare by 5.7% during the 3rd quarter. Applied Finance Capital Management LLC now owns 1,408 shares of the company’s stock valued at $269,000 after purchasing an additional 76 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Molina Healthcare by 0.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,668 shares of the company’s stock valued at $2,616,000 after purchasing an additional 92 shares during the period. Public Employees Retirement System of Ohio raised its stake in shares of Molina Healthcare by 0.6% in the third quarter. Public Employees Retirement System of Ohio now owns 16,753 shares of the company’s stock worth $3,206,000 after purchasing an additional 104 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in shares of Molina Healthcare by 35.4% in the third quarter. UMB Bank n.a. now owns 432 shares of the company’s stock worth $83,000 after purchasing an additional 113 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. This represents a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by insiders.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $184.08 on Friday. The company has a market capitalization of $9.59 billion, a P/E ratio of 54.46 and a beta of 0.85. The business’s 50 day moving average is $160.73 and its two-hundred day moving average is $159.79. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $312.85.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. During the same period in the previous year, the business earned $6.08 earnings per share. The business’s revenue was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.

Analyst Ratings Changes

MOH has been the topic of a number of recent research reports. UBS Group upped their target price on Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research report on Friday. Morgan Stanley lifted their price objective on shares of Molina Healthcare from $128.00 to $146.00 and gave the company an “equal weight” rating in a research note on Friday, April 24th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $129.00 price objective on shares of Molina Healthcare in a report on Friday, April 24th. Wall Street Zen raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. Three equities research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and an average target price of $176.00.

Molina Healthcare Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.